Oncogenic Kras targeting with MRTX1133 or Daraxonrasib specifically synergize with anti-CTLA4 to promote anti-tumor immunity in pancreatic cancer
- Krishnan K. Mahadevan
- Ana S. Maldonado
- Bingrui Li
- Aaron A. Bickert
- Adrian Kacperczyk-Perdyan
- Shreyasee V. Kumbhar
- Sujan Piya
- Amari M. Sockwell
- Sami J. Morse
- Kent Arian
- Hikaru Sugimoto
- Shabnam Shalapour
- David S. Hong
- Timothy P. Heffernan
- Anirban Maitra
- Raghu Kalluri
2026-07-27